IDS-ISYS IFG-I CONTROL SET— 510(k) K110412

Name: FDA 510(k) clearance K110412
Creator: U.S. Food and Drug Administration
Published: 2011-03-16

Substantially Equivalent

Immunodiagnostic Systems , Ltd.

FDA 510(k) clearance K110412 for IDS-ISYS IFG-I CONTROL SET, Substantially Equivalent on 2011-03-16. Applicant: Immunodiagnostic Systems , Ltd.. Device class: 1.

Clearance details

Applicant: Immunodiagnostic Systems , Ltd.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 2011-02-14
Decision date: 2011-03-16
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Boldon, Tyne & Wear, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Immunodiagnostic Systems , Ltd.

view all

K202136 — IDS Cortisol2021-04-13
K200475 — IDS-iSYS Ostase BAP2020-09-30
K190121 — IDS SHBG2019-06-17
K161158 — IDS-iSYS Intact PTHN2017-01-31
K161831 — IDS-iSYS 25VitDs, IDS-iSYS 25VitDs Control Set2016-11-15

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.